Generic Pharmaceuticals Businesses for Sale and Investment Opportunities

- API manufacturing company based in Indore, India. For the past 3 decades, this company has focused on API development, manufacturing, and marketing of APIs and intermediates. It has a state-of-the-art manufacturing facility and is a state GMP-certified plant facility. - This is a research-driven organization – that develops technology, translates it to production, and then delivers it to customers. With a strong commitment to excellence in product quality (which is never compromised) and adherence to strict delivery schedules, they are presently exporting to 14 countries around the world. - The company’s strength lies in providing extended support to its customers. Their success has been validated by what they hold the dearest – product excellence and customer service. The company believes that long-term business is rooted in values and business ethics. - It is one of the leading manufacturers of Tinidazole and Ornidazole, which are considered anti-protozoal molecules, a segment of bulk drugs. Sales have shown an increasing trend. - The company has received Good Manufacturing Practices (GMP) Certificate from the Office of the Controller of Food and Drugs Administration, Madhya Pradesh. Note: this transaction is being handled by an advisory firm based in Rajkot.

- Our research and development department reflects our full commitment to delivering to society. - The revolutionary pharmaceuticals, acquired through groundbreaking ideas and high-standard research and development by each individual employee challenge innovation, so as to help enable patients and their families to lead healthier and more fulfilling lives. It also expresses our corporate mission symbolically, cooperating with a wide range of companies worldwide. - With a wide variety of drugs and a tradition in manufacturing for needs, we have cooperated with companies from Spain, Italy, and Turkey, looking forward to offering a wide range of healthcare products, also for well-being, with pre-ordered dosage forms for your efficiency and gut health. - The promoter is an investor representing the company who is based out of Istanbul.

- We are an Oman-based company, with offices in the UK and India, manufacturing our own products in a GMP-certified European facility. - The formulations are done by us and the production is outsourced. - Currently, 7 SKUs/products have been launched in Oman. - We are ready to launch the products in other GCC countries and need funds to start operations in the GCC region immediately. - Our products had an excellent response in Oman. - Our sister concern is the distributor for Oman, and we have appointed one distributor for each GCC country. - The full company name and other details are to be shared upon connecting and assessing the investor. - Promoters have 13 years of experience in the field.

- We are dealing with the pharmaceutical segment as well as in personnel care products like skin and hair care. - We do not have our own manufacturing unit but give for third-party manufacturing and sell them under our own brand. - Currently supplying to 500 retailers in and around Varanasi. - The promoter has over 20 years of experience in this industry. - We are planning to expand our business hence we have 8 employees.

- Well established pharmaceutical company that has been operational for over 22 years. - Company manufactures and sells generic medicines under our own brand name. - Company has 3 directors and has no liability. - Business has its own manufacturing facility and has also partnered with other manufacturers to produce medicines. - Medicines are sold to doctors, pharma chains and distributors.

- We are a pharmaceutical trade (sales) business with 13 years of experience. - We plan on starting our own capsule manufacturing plant and seek investment for the same. - Have already acquired an industrial land on lease in Madhya Pradesh. - Business has connections in the pharmaceutical industry all over India. - The plant will be equipped with the latest machinery and equipment. - Have estimated a turnover of INR 15 crore in the 1st year based on the market conditions and the future manufacturing potential of the business. - There are 2 partners in the business with 75%-25% shareholding. - Business is debt-free.

- We are a generic pharmaceutical business. - Manufacturing is done by a third party and the products are sold under our brand name. - Our representatives approach doctors to inform them about our products and get orders for them. - Business is managed by 2 people with an equal stake in it. - Business is debt-free.

- Generic medicine manufacturing company that was started in 1992 and now the operations have been stopped. - We used to produce medicines for other clients. We were a B2B business. - We would like to sell only the assets and not the brand name, legal entity. - Production capacity depends on the type of medicines and it is approx 100 metric tonnes per month. - Company has no loans and is completely owned by the family members. - This purchase would be ideal for an existing company looking for expansion or for a new business. - Business is registered in Kolkata and located in Ahmedabad. - We used to generate an annual turnover of INR 7-8 crore with 18% EBITDA. - Assets include 1,800 sq m land with a building, plant, and machinery. The main machinery is 22 reactors with a combined capacity of 6,500 kilolitres. The size of each reactor is 1,000 to 10,000 litres. More asset details can be shared with the buyer. - If the buyer does not want to purchase the property, it is also available for a long term lease.

- Our business is essentially a pharmaceutical marketing company that sells a broad range of medicines from multiple brands to its clients. - We have about 60 clients who are essentially pharmaceutical companies and international distributors in the East African countries like Kenya, Burundi, Malawi, etc. These clients provide us with recurring purchase orders. - The entire revenue of the company is generated through the export of these medicines to our clients. There are no domestic clients. However, we will soon commence undertaking clients in India as well. - Currently, we are dealing in 39 different brand names such as Cipla, Glenmark, etc. The products are supplied on the basis of purchase orders received. Logistics support is outsourced. This line of operations contributing to 100 percent of the company's revenue. - We are now seeking to expand our operations and start our own pharmaceutical brand name & manufacturing unit. The majority of the proceeds from this investment will be used to start the manufacturing unit. - The prospective investor will receive a 50 percent ownership of the entire registered business entity which includes pharma marketing, third-party medicine manufacturing, and generic pharmaceutical brand name lines of operations. These three will simple be different domains services under one company. - Our business is extremely valuable due to the owner's long standing relationships in the industry and enormous growth potential in the future. The valuation is based on our own estimate. - The business is registered in Raigarh, Maharashtra. However, we run operations from Navi Mumbai, Maharashtra. - Our business is entirely debt-free with no outstanding business loans, overdue, or defaults. - The company has two directors. One of them has a 75 percent ownership of the business. The other owns the remaining 25 percent of the business. There are no outside investors or shareholders.

- Pharmaceutical company that markets and sells medicines under its own brand across Uttarakhand and west Uttar Pradesh. - Company completely outsources the manufacturing to 2-3 vendors. - The company has products in the form of tablets, capsules, and syrup for gynaecology, respiratory, and gastroenteritis problems. - We have more than 100 hospitals as clients and 60+ pharmacy stores. - Currently, we have 40 products under our brand. - The company is debt-free and has 2 directors with equal shares.